These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9000097)

  • 1. Persistent infection of mammalian cells by Rift Valley fever virus.
    Billecocq A; Vialat P; Bouloy M
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3053-62. PubMed ID: 9000097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment.
    Ikegami T; Won S; Peters CJ; Makino S
    J Virol; 2005 Sep; 79(18):12106-11. PubMed ID: 16140788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of infectious virus and serological detection of virus antigen in Rift Valley fever virus-exposed mosquitoes fixed with paraformaldehyde.
    Kading R; Crabtree M; Miller B
    J Virol Methods; 2013 Apr; 189(1):184-8. PubMed ID: 23391826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
    Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
    Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses.
    Habjan M; Penski N; Wagner V; Spiegel M; Overby AK; Kochs G; Huiskonen JT; Weber F
    Virology; 2009 Mar; 385(2):400-8. PubMed ID: 19155037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses.
    Billecocq A; Gauliard N; Le May N; Elliott RM; Flick R; Bouloy M
    Virology; 2008 Sep; 378(2):377-84. PubMed ID: 18614193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation.
    Vialat P; Muller R; Vu TH; Prehaud C; Bouloy M
    Virus Res; 1997 Nov; 52(1):43-50. PubMed ID: 9453143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.
    Garcia S; Crance JM; Billecocq A; Peinnequin A; Jouan A; Bouloy M; Garin D
    J Clin Microbiol; 2001 Dec; 39(12):4456-61. PubMed ID: 11724861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strand-specific real-time quantitative RT-PCR assay for distinguishing the genomic and antigenomic RNAs of Rift Valley fever phlebovirus.
    Tercero B; Terasaki K; Nakagawa K; Narayanan K; Makino S
    J Virol Methods; 2019 Oct; 272():113701. PubMed ID: 31315022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
    Lorenzo G; Martín-Folgar R; Rodríguez F; Brun A
    Vaccine; 2008 Sep; 26(41):5255-62. PubMed ID: 18682268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection.
    Gerrard SR; Bird BH; Albariño CG; Nichol ST
    Virology; 2007 Mar; 359(2):459-65. PubMed ID: 17070883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of Nanotrap particles in the enhanced detection of Rift Valley fever virus nucleoprotein.
    Shafagati N; Lundberg L; Baer A; Patanarut A; Fite K; Lepene B; Kehn-Hall K
    PLoS One; 2015; 10(5):e0128215. PubMed ID: 26020252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H; Lorenzo G; Rodriguez F; Brun A
    Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse model for the Rift Valley fever virus MP12 strain infection.
    Lang Y; Henningson J; Jasperson D; Li Y; Lee J; Ma J; Li Y; Cao N; Liu H; Wilson W; Richt J; Ruder M; McVey S; Ma W
    Vet Microbiol; 2016 Nov; 195():70-77. PubMed ID: 27771072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome.
    Lorenzo G; Rodríguez-Pulido M; López-Gil E; Sobrino F; Borrego B; Sáiz M; Brun A
    Antiviral Res; 2014 Sep; 109():64-7. PubMed ID: 24973761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Rift Valley fever virus viremia challenge model in sheep and goats.
    Weingartl HM; Miller M; Nfon C; Wilson WC
    Vaccine; 2014 Apr; 32(20):2337-44. PubMed ID: 24631070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of attenuated strains of Rift Valley fever virus.
    Rossi CA; Turell MJ
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():817-23. PubMed ID: 3356978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins.
    Liu L; Celma CC; Roy P
    Virol J; 2008 Jul; 5():82. PubMed ID: 18638365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and expression of viral antigens in Vero cells persistently infected with Junin virus.
    Ellenberg P; Edreira M; Lozano M; Scolaro L
    Arch Virol; 2002 Aug; 147(8):1543-57. PubMed ID: 12181674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.